Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366431712> ?p ?o ?g. }
- W4366431712 abstract "The leading cause of mortality in patients with rheumatoid arthritis is atherosclerotic cardiovascular disease (CVD). We have shown that murine arthritis impairs atherosclerotic lesion regression, because of cellular cholesterol efflux defects in haematopoietic stem and progenitor cells (HSPCs), causing monocytosis and impaired atherosclerotic regression. Therefore, we hypothesised that improving cholesterol efflux using a Liver X Receptor (LXR) agonist would improve cholesterol efflux and improve atherosclerotic lesion regression in arthritis.Ldlr-/- mice were fed a western-type diet for 14 weeks to initiate atherogenesis, then switched to a chow diet to induce lesion regression and divided into three groups; (1) control, (2) K/BxN serum transfer inflammatory arthritis (K/BxN) or (3) K/BxN arthritis and LXR agonist T0901317 daily for 2 weeks.LXR activation during murine inflammatory arthritis completely restored atherosclerotic lesion regression in arthritic mice, evidenced by reduced lesion size, macrophage abundance and lipid content. Mechanistically, serum from arthritic mice promoted foam cell formation, demonstrated by increased cellular lipid accumulation in macrophages and paralleled by a reduction in mRNA of the cholesterol efflux transporters Abca1, Abcg1 and Apoe. T0901317 reduced lipid loading and increased Abca1 and Abcg1 expression in macrophages exposed to arthritic serum and increased ABCA1 levels in atherosclerotic lesions of arthritic mice. Moreover, arthritic clinical score was also attenuated with T0901317.Taken together, we show that the LXR agonist T0901317 rescues impaired atherosclerotic lesion regression in murine arthritis because of enhanced cholesterol efflux transporter expression and reduced foam cell development in atherosclerotic lesions." @default.
- W4366431712 created "2023-04-21" @default.
- W4366431712 creator A5013003637 @default.
- W4366431712 creator A5014203080 @default.
- W4366431712 creator A5018043741 @default.
- W4366431712 creator A5035416436 @default.
- W4366431712 creator A5036079859 @default.
- W4366431712 creator A5046060573 @default.
- W4366431712 creator A5047139735 @default.
- W4366431712 creator A5057028052 @default.
- W4366431712 creator A5060070593 @default.
- W4366431712 creator A5062946947 @default.
- W4366431712 creator A5068012232 @default.
- W4366431712 creator A5068703844 @default.
- W4366431712 creator A5069608766 @default.
- W4366431712 creator A5072152104 @default.
- W4366431712 creator A5075712626 @default.
- W4366431712 creator A5079876374 @default.
- W4366431712 creator A5087477908 @default.
- W4366431712 date "2023-01-01" @default.
- W4366431712 modified "2023-10-15" @default.
- W4366431712 title "Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis" @default.
- W4366431712 cites W1841637395 @default.
- W4366431712 cites W1909688331 @default.
- W4366431712 cites W1964657490 @default.
- W4366431712 cites W1967090600 @default.
- W4366431712 cites W1970845955 @default.
- W4366431712 cites W1973450751 @default.
- W4366431712 cites W1997046636 @default.
- W4366431712 cites W1998572091 @default.
- W4366431712 cites W2002072152 @default.
- W4366431712 cites W2008811967 @default.
- W4366431712 cites W2026587556 @default.
- W4366431712 cites W2026962303 @default.
- W4366431712 cites W2038772512 @default.
- W4366431712 cites W2052735059 @default.
- W4366431712 cites W2057086747 @default.
- W4366431712 cites W2062798105 @default.
- W4366431712 cites W2070088851 @default.
- W4366431712 cites W2081832076 @default.
- W4366431712 cites W2105609701 @default.
- W4366431712 cites W2110997510 @default.
- W4366431712 cites W2117219551 @default.
- W4366431712 cites W2117901133 @default.
- W4366431712 cites W2133701923 @default.
- W4366431712 cites W2142125671 @default.
- W4366431712 cites W2143786800 @default.
- W4366431712 cites W2145899814 @default.
- W4366431712 cites W2145991777 @default.
- W4366431712 cites W2152226311 @default.
- W4366431712 cites W2153673003 @default.
- W4366431712 cites W2158380859 @default.
- W4366431712 cites W2159332620 @default.
- W4366431712 cites W2160427887 @default.
- W4366431712 cites W2161472677 @default.
- W4366431712 cites W2163092745 @default.
- W4366431712 cites W2164159495 @default.
- W4366431712 cites W2165802048 @default.
- W4366431712 cites W2166118660 @default.
- W4366431712 cites W2170535838 @default.
- W4366431712 cites W2261633758 @default.
- W4366431712 cites W2403798563 @default.
- W4366431712 cites W2413191746 @default.
- W4366431712 cites W2495036841 @default.
- W4366431712 cites W2611459561 @default.
- W4366431712 cites W2737124267 @default.
- W4366431712 cites W2792912137 @default.
- W4366431712 cites W2799794258 @default.
- W4366431712 cites W2808548053 @default.
- W4366431712 cites W2810856837 @default.
- W4366431712 cites W2899711354 @default.
- W4366431712 cites W2906517193 @default.
- W4366431712 cites W3099917933 @default.
- W4366431712 cites W3210696507 @default.
- W4366431712 cites W4210363776 @default.
- W4366431712 cites W4230088158 @default.
- W4366431712 cites W4232411700 @default.
- W4366431712 doi "https://doi.org/10.1002/cti2.1446" @default.
- W4366431712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37091327" @default.
- W4366431712 hasPublicationYear "2023" @default.
- W4366431712 type Work @default.
- W4366431712 citedByCount "0" @default.
- W4366431712 crossrefType "journal-article" @default.
- W4366431712 hasAuthorship W4366431712A5013003637 @default.
- W4366431712 hasAuthorship W4366431712A5014203080 @default.
- W4366431712 hasAuthorship W4366431712A5018043741 @default.
- W4366431712 hasAuthorship W4366431712A5035416436 @default.
- W4366431712 hasAuthorship W4366431712A5036079859 @default.
- W4366431712 hasAuthorship W4366431712A5046060573 @default.
- W4366431712 hasAuthorship W4366431712A5047139735 @default.
- W4366431712 hasAuthorship W4366431712A5057028052 @default.
- W4366431712 hasAuthorship W4366431712A5060070593 @default.
- W4366431712 hasAuthorship W4366431712A5062946947 @default.
- W4366431712 hasAuthorship W4366431712A5068012232 @default.
- W4366431712 hasAuthorship W4366431712A5068703844 @default.
- W4366431712 hasAuthorship W4366431712A5069608766 @default.
- W4366431712 hasAuthorship W4366431712A5072152104 @default.
- W4366431712 hasAuthorship W4366431712A5075712626 @default.
- W4366431712 hasAuthorship W4366431712A5079876374 @default.
- W4366431712 hasAuthorship W4366431712A5087477908 @default.